Anthony Y. Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anthony Y. Zhu has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Richard T. Lee
Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA
2 shared publications Angie Delgado
Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, Cambridge, MA (A.Y.Z., M.S.C., A.M.T.B., L.B.D., E.K.G., U.-S.D., A.D., N.N., R.T.L.).
1 shared publicationAnnika M.T. Braun
Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, Cambridge, MA (A.Y.Z., M.S.C., A.M.T.B., L.B.D., E.K.G., U.-S.D., A.D., N.N., R.T.L.).
1 shared publication- Ayellet V. Segrè
Department of Ophthalmology, Harvard Medical School, Boston, MA, USA
1 shared publication - Bogdan Pasaniuc
Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
1 shared publication - Chelsea Jui-Ting Ju
UCLA
1 shared publication
Latest Publications
- 24 March 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (12) , 941-944
Epicardial Complement C3 Activation in Neonatal Cardiac Regeneration
- 24 March 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (12) , 941-944
Epicardial Complement C3 Activation in Neonatal Cardiac Regeneration
- 13 November 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 390 (6774) , eadw4612
Flexible nanoelectronics reveal arrhythmogenesis in transplanted human cardiomyocytes
The transplantation of human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) offers a potential treatment for heart failure, but arrhythmogenic automaticity can arise from these transplanted cells. In this study, we investigated the effects of RADA16, a clinically approved self-assembling peptide that forms nanofibers after injection, on the vascularization, myofibril structure, and electrophysiological adaptation of hiPSC-CMs transplanted into rat hearts. RADA16 accelerated the transition of hiPSC-CMs toward adultlike gene expression profiles, enhanced sarcomere organization, and improved vascularization in the transplanted site. Flexible mesh nanoelectronics revealed fibrillation of transplanted hiPSC-CMs within the beating recipient heart, and RADA16 drastically reduced the automaticity of hiPSC-CMs. Our findings demonstrate the potential of self-assembling nanofibers to advance cardiac cell therapy and how flexible mesh nanoelectronics technology could improve safety.
- 13 November 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 390 (6774) , eadw4612
Flexible nanoelectronics reveal arrhythmogenesis in transplanted human cardiomyocytes
The transplantation of human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) offers a potential treatment for heart failure, but arrhythmogenic automaticity can arise from these transplanted cells. In this study, we investigated the effects of RADA16, a clinically approved self-assembling peptide that forms nanofibers after injection, on the vascularization, myofibril structure, and electrophysiological adaptation of hiPSC-CMs transplanted into rat hearts. RADA16 accelerated the transition of hiPSC-CMs toward adultlike gene expression profiles, enhanced sarcomere organization, and improved vascularization in the transplanted site. Flexible mesh nanoelectronics revealed fibrillation of transplanted hiPSC-CMs within the beating recipient heart, and RADA16 drastically reduced the automaticity of hiPSC-CMs. Our findings demonstrate the potential of self-assembling nanofibers to advance cardiac cell therapy and how flexible mesh nanoelectronics technology could improve safety.
- Open Access
Widespread allelic heterogeneity in complex traits
Recent successes in genome-wide association studies (GWASs) make it possible to address important questions about the genetic architecture of complex traits, such as allele frequency and effect size. One lesser-known aspect of complex traits is the extent of allelic heterogeneity (AH) arising from multiple causal variants at a locus. We developed a computational method to infer the probability of AH and applied it to three GWAS and four expression quantitative trait loci (eQTL) datasets. We identified a total of 4152 loci with strong evidence of AH. The proportion of all loci with identified AH is 4-23% in eQTLs, 35% in GWAS of High-Density Lipoprotein (HDL), and 23% in schizophrenia. For eQTLs, we observed a strong correlation between sample size and the proportion of loci with AH ( R 2 =0.85, P = 2.2e-16), indicating that statistical power prevents identification of AH in other loci. Understanding the extent of AH may guide the development of new methods for fine mapping and association mapping of complex traits.
Open AccessWidespread allelic heterogeneity in complex traits
Recent successes in genome-wide association studies (GWASs) make it possible to address important questions about the genetic architecture of complex traits, such as allele frequency and effect size. One lesser-known aspect of complex traits is the extent of allelic heterogeneity (AH) arising from multiple causal variants at a locus. We developed a computational method to infer the probability of AH and applied it to three GWAS and four expression quantitative trait loci (eQTL) datasets. We identified a total of 4152 loci with strong evidence of AH. The proportion of all loci with identified AH is 4-23% in eQTLs, 35% in GWAS of High-Density Lipoprotein (HDL), and 23% in schizophrenia. For eQTLs, we observed a strong correlation between sample size and the proportion of loci with AH ( R 2 =0.85, P = 2.2e-16), indicating that statistical power prevents identification of AH in other loci. Understanding the extent of AH may guide the development of new methods for fine mapping and association mapping of complex traits.